Friday 31 January 2014

Pulmonology Top News: Spiriva Signal, LABA Risk

(MedPage Today) -- A heart attack signal with tiotropium (Spiriva) and a potential genetic explanation for severe adverse events with long-acting beta agonists (LABAs) in asthma topped the news in pulmonology this week. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment